Michaela Romero

Recommended Articles

• What Is Ischemia? Treatment for Acute or Chronic Ischemia

  What is ischemia?Ischemia is the medical term used to describe a lack of blood flow to certain organs or body parts. Since the blood carries oxygen and other necessary nutrients to parts of the body, when blow flow is reduced these body parts do not receive the adequate amount of oxygen and...

• New Explanation for How Ovarian Cancer Spreads

  In their latest publication, a team of researchers with the University of California, Riverside and the University of Notre Dame have revealed a new explanation for how ovarian cancer spreads (or metastasizes). The researchers used electron microscopy and live imaging to study the cellular...

• Bronchitis: Causes, Risk Factors, and Symptoms

  Acute bronchitis is mainly caused by a viral infection, whereas cigarette smoking is the most common cause of chronic bronchitis.Causes of acute bronchitisAcute bronchitis can be caused viral and bacterial organisms. Out of all, the most common viruses responsible for acute bronchitis include...

• What a Lung Transplantation for Cystic Fibrosis Is Really Like

  Cystic fibrosis has been one of the more devastating and debilitating diseases to take hold of the population. The condition has forced countless research studies, clinical trials, and innovative treatments to try and mitigate the symptoms and effects of cystic fibrosis. One of the riskier but...

• High Frequency of Hospital Visits Could Indicate Lupus

  Recent studies have suggested another indicator that might help to identify an underlying lupus diagnosis. The study called “High Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth,” which is published in the journal Arthritis Care & Research, states that,...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...